DexCom, Inc. Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
DexCom (DXCM) PT Lowered to $92 at Oppenheimer Following 2Q
August 2, 2017 9:36 AM EDTOppenheimer lowered its price target on DexCom (NASDAQ: DXCM) to $92.00 (from $98.00) while maintaining a Outperform rating. 2Q17 revenue of $170.6M was ahead of the consensus estimate of $166.6M. The beat was both in the US and international. US sales were ~$140.8M, above... More
DexCom (DXCM) Tops Q2 EPS by 5c, Names CFO
August 1, 2017 4:32 PM EDTDexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.16), $0.05 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $170.6 million versus the consensus estimate of $166.3 million.
DexCom Appoints New CFO
In conjunction with its earnings release, DexCom announced that Quentin Blackford has... More
